Imperva (IMPV) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Oppenheimer Remains Bullish on Imperva (IMPV) Following 1Q Beat
May 6, 2016 9:46 AM EDTOppenheimer maintained an Outperform rating on Imperva (NYSE: IMPV), and cut the price target to $60.00 (from $70.00), following the company's 1Q earnings report. Revenue came in at $59.8M, ahead of the consensus of $59.5M. EPS of $0.20, bested the Street's $0.28 estimate. 2Q16 revenues were guided... More
Needham & Company Downgrades Imperva (IMPV) to Hold
May 6, 2016 7:32 AM EDTNeedham & Company downgraded Imperva (NYSE: IMPV) from Buy to Hold.
Analyst Scott Zeller commented, "MarQ was in-line for Imperva on revenues and loss per share - surprising given the favorable security spending climate. In field discussions, we have heard IMPV has strong... More
